Mahesh Asawa Chandra
Director/Board Member bij Unidrug Innovative Pharma Technologies Ltd.
Profiel
Mahesh Asawa Chandra is currently an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
and a Fellow Member at The Institute of Chartered Accountants of India.
He has an undergraduate and graduate degree from Devi Ahilya University.
Actieve functies van Mahesh Asawa Chandra
| Bedrijven | Functie | Begin |
|---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Director/Board Member | 20-09-2018 |
| The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Opleiding van Mahesh Asawa Chandra
| Devi Ahilya University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
